Scientists at the University of Liverpool and the Royal Liverpool University Hospital have completed human trials on a drug that has proved successful in preventing the development of a rare bone disease.
Dec 08, 2014
5 / 5 (2) | 0
(HealthDay)—Oral contraceptive (OC) use does not appear to be associated with the risk of rheumatoid arthritis (RA), although there is an inverse association between OC use and RA severity, according to ...
Dec 09, 2014
5 / 5 (1) | 0